sematilide has been researched along with Arrhythmias, Cardiac in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Argentieri, TM; Gomez, RP; Lind, JM; Morgan, TK; Nickisch, K; Phillips, GB; Sullivan, ME; Wohl, RA | 1 |
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Hashimoto, K; Ishida, Y; Kugiyama, K; Satoh, Y; Sugiyama, A; Yoneyama, M; Yoshida, H | 1 |
Al-Khalidi, H; Brooks, RR; Drexler, AP; Kostreva, DR; Maynard, AE | 1 |
Honerjäger, P; Schmidt, G | 1 |
Birgersdotter, UM; Hilleman, DE; Mohiuddin, SM; Pavlou, HN; Roden, DM; Wong, W | 1 |
1 review(s) available for sematilide and Arrhythmias, Cardiac
Article | Year |
---|---|
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
1 trial(s) available for sematilide and Arrhythmias, Cardiac
Article | Year |
---|---|
Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Half-Life; Humans; Procainamide; Torsades de Pointes | 1992 |
5 other study(ies) available for sematilide and Arrhythmias, Cardiac
Article | Year |
---|---|
Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Dogs; Drug Design; Electrophysiology; Guinea Pigs; In Vitro Techniques; Ouabain; Procainamide; Purkinje Fibers; Structure-Activity Relationship | 1990 |
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Female; Heart Block; Male; Procainamide; Torsades de Pointes | 2002 |
Sematilide. CK 1752, CK 1752A, ZK 110516.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Drug Interactions; Drugs, Investigational; Humans; Potassium Channel Blockers; Procainamide; Rats | 1999 |
Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Female; Hemodynamics; Hydantoins; Imidazoles; Imidazolidines; Male; Methoxamine; Phenethylamines; Piperazines; Procainamide; Quaternary Ammonium Compounds; Rabbits; Sotalol; Sulfonamides | 2000 |